Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — Q1 FY2025 Earnings Presentation

37 slides from Mitsui Chemicals's earnings presentation, Aug 7, 2025

  1. Slide 1: Financial Summary: Results for 1st Quarter of FY2025 & Outlook for 1st Half of FY2025

    Financial Summary Results for 1st Quarter of FY2025 & Outlook for 1st Half of FY2025 Mitsui Chemicals, Inc. ＜Remarks＞ Aug 7, 2025 FY2025 indicates the period from April 1, 2025 to March 31, 2026. This summary contains forward-looking statements about the future plans, strategies, belief and performa

  2. Slide 2: Contents

    1. Executive Summary Contents 1）Executive Summary: 1Q FY2025 Earnings Announcement ・・・1 2）Executive Summary: 1Q FY2025 Financial Results (Operating Income before Special Items) ・・・2 3）Executive Summary: 1H FY2025 Financial Outlook (Operating Income before Special Items) ・・・3 2. Results for 1st Quart

  3. Slide 3: 1. Executive Summary

    1. Executive Summary Copyright © 2025 Mitsui Chemicals, Inc.

  4. Slide 4: Executive Summary: 1Q FY2025 Earnings Announcement

    1) Executive Summary: 1Q FY2025 Earnings Announcement ➢ Sales in the specialty chemicals domains have been firm, leading to solid progress in operating income before special items. ➢ As a result of steady progress in business restructuring, we recorded impairment losses in connection with the phenol

  5. Slide 5: Executive Summary: 1Q FY2025 Results (Operating Income before Special Items)

    2) Executive Summary: 1Q FY2025 Results (Operating Income before Special Items) ➢ Operating income before special items for the entire Group decreased to 26.6 billion yen in 1Q FY2025, down 3.6 billion yen (-12%) YoY, primarily due to inventory valuation losses (including time-lag effects of sales p

  6. Slide 6: Executive Summary: 1H FY2025 Outlook (Operating Income before Special Items)

    3) Executive Summary: 1H FY2025 Outlook (Operating Income before Special Items) ➢ Operating income before special items for the entire Group is expected to be 49.0 billion yen in 1H FY2025, or a decrease of 3.8 billion yen (-7%) YoY, as the expected profit increase of 1.5 billion yen in the specialt

  7. Slide 7: 2. Results for 1st Quarter of FY2025

    2. Results for 1st Quarter of FY2025 (April 1, 2025 – June 30, 2025) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as tha

  8. Slide 8: Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2025 FY2025 1H 1Q→ (changes from FY2024 1Q 2Q 2Q 1H) Ophthalmic lens materials market Firm demand Firm demand expected Firm demand Life ＆ Healthcare Solutions Firm demand; inventory level Firm demand expected; inventory level Agrochemicals market adjustments seen

  9. Slide 9: Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY23 FY24 FY25 FY26~ Life & Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan January.'24 - Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan Healthcare (Announced on

  10. Slide 10: Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2024 FY2025 Increase Items % 1Q 1Q (Decrease) Sales revenue 449.5 415.4 (34.1) (8%) Operating income before special items 30.2 26.6 (3.6) (12%) (inc. Equity in earnings) 3.6 4.4 0.8 22% Non-recurring items (3.0) (13.8) (10

  11. Slide 11: Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials increased due to firm demand. ［+］ ・Agrochemicals increased due to firm demand. ［+］ Volume ・Elastomers increased due to expansion of products into multiple applic

  12. Slide 12: Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2024 FY2025 Incr. FY2024 FY2025 Incr. Terms of Volume Cos

  13. Slide 13: Life & Healthcare Solutions: Operating Income and Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger Vision care

  14. Slide 14: Mobility Solutions: Operating Income and Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume increa

  15. Slide 15: ICT Solutions: Operating Income and Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume was up due

  16. Slide 16: Basic & Green Materials: Operating Income and Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [-]Sales volume

  17. Slide 17: Non-recurring Items

    6) Non-recurring Items (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items Comments 1Q 1Q (Decr.) 25.1Q Impairment loss (3.1) (12.4) (9.3) Transfer of Equity Interest of PH business joint venture@China* -12.4 25.1Q Loss on related business ー (0.9) (0.9) Business restructuring: Kulzer、ARRK

  18. Slide 18: Consolidated Statement of Financial Position

    7) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar.2025 Jun.2025 (Decr.) Mar.2025 Jun.2025 (Decr.) Current assets 1,041.2 999.5 (41.7) Liabilities 1,183.4 1,154.7 (28.7) Cash and cash 170.6 180.5 9.9 Operating

  19. Slide 19: Consolidated Statement of Cash Flows

    8) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items 1Q 1Q (Decr.) Ⅰ．Cash flows from operating activities (a) 39.8 45.4 5.6 ( of which Working capital ) 5.0 28.2 23.2 Ⅱ．Cash flows from investing activities (b) (23.9) (24.7) (0.8) ( of which cash infl

  20. Slide 20: 3. Outlook for 1st Half of FY2025

    3. Outlook for 1st Half of FY2025 (April 1, 2025 – September 30, 2025) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as t

  21. Slide 21: Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2025 FY2024 Incr.(Decr.) Outlook Items 1st Half 1st Half 1st Half ％ Sales revenue 890.4 818.0 (72.4) (8%) Operating income before special items 52.8 49.0 (3.8) (7%) Non-recurring items (6.8) (18.0) (11.2) ー Oper

  22. Slide 22: Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-2) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials expected to increase on the back of firm demand. ［+］ ・Agrochemicals expected to increase due to firm demand. ［+］ Volume ・Elastomers expected to increa

  23. Slide 23: Sales Revenue and Operating Income Outlook by Business Segment

    2) Sales Revenue and Operating Income before Special Items of Outlook by Business Segment (compared with corresponding period of FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2024 FY2025 FY2024 FY2025 Terms of Incr.(Decr.

  24. Slide 24: Life & Healthcare Solutions: Outlook and Business Overview

    3-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger

  25. Slide 25: Mobility Solutions: Outlook and Business Overview

    3-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales vo

  26. Slide 26: ICT Solutions: Outlook and Business Overview

    3-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger Semiconductor

  27. Slide 27: Basic & Green Materials: Outlook and Business Overview

    3-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [-]S

  28. Slide 28: Operating Income before Special Items by Business Segment (2Q vs. 1Q of FY2025)

    4) Operating Income before Special Items by Business Segment (2Q vs. 1Q of FY2025) (Billions of Yen) () Denotes a minus Operating income before special items Comments FY2025 Segment 2Q [+] denotes profit trigger 1Q Incr.(Decr.) [-] denotes loss trigger Outlook Life & Healthcare 6.2 7.8 1.6 [+]Sales

  29. Slide 29: Consolidated Statement of Cash Flows

    5) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2025 FY2024 Outlook Items Incr.(Decr.) 1st Half 1st Half Ⅰ．Cash flows from operating activities (a) 118.0 116.0 (2.0) Ⅱ．Cash flows from investing activities (b) (48.3) (70.0) (21.7) Free cash flows (a)+(b) 69.7 46.0 (23.7

  30. Slide 30: 4. Appendix

    4. Appendix 1) Trends in Product Prices 2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 3) Sales Revenue and Operating Income before Special Items by Business Segment 4) Outline of Business Segments 5) Data Highlights Copyright © 2025 Mitsui Chemicals, Inc.

  31. Slide 31: Trends in Product Prices

    1) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan): Change in Prices and Raw Materials Prices in Japan / TDI: Chinese Market Price) (ACP) : Asian contract price Year 2022 2023 2024 2025 Month Jul.-Sep. Oct.-Dec. Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct

  32. Slide 32: Sales Revenue Increase/Decrease (Year on Year) by Business Segment

    ２)Sales Revenue Increase/Decrease（Year on Year）by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Breakdown Segment Comments FY2024 FY2025 Incr.(Decr.) Volume Prices 1Q 1Q Life & Healthcare Volume）Sales of vision care were firm. 56.6 56.3 (0.3) 1.7 (2.0) Solutions Prices）Foreign

  33. Slide 33: Sales Revenue and Operating Income before Special Items by Business Segment

    3) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue* FY2024 FY2025 Segment Jul-Sep Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Outlook Life & Healthcare Solutions 56.6 58.9 57.3 78.9 56.3 58.7 Mobility Solutions 140.3 136.5 13

  34. Slide 34: Outline of Business Segments

    4) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Life & Healthcare Medical materials (taurine), Oral Care, Agrochemicals Solutions Oral care materials (restoratives, adhesives, digital equipme

  35. Slide 35: Data Highlights

    5-1) Data Highlights ～FY19：J-GAAP / FY20～：IFRS () Denotes a minus （Billions of Yen） Total Assets （Billions of Yen） 2,500 Net Sales/Sales Revenue 2,400 2,215.8 2,154.0 2,200 2,068.2 1,879.5 1,935.0 2,000 1,749.7 1,809.2 1,770.0 2,000 1,482.9 1,612.7 1,339.0 1,800 1,500 1,211.7 1,558.1 1,600 1,501.1 1

  36. Slide 36: Data Highlights

    5-2) Data Highlights ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） 250.0 Capital Expenditure （Billions of Yen） Depreciation & Amortization 207.1 185.7 150.0 200.0 168.0 145.2 154.0 *2 109.0 150.0 *1 92.1 95.2 99.8 93.2 100.0 76.6 84.2 100.0 76.3 61.9 49.5 52.1 50.0 50.0 0.0 0.0 '18 '19 '20 '21 '22 '23

  37. Slide 37: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2025 Mitsui Chemicals, Inc.

Mitsui Chemicals — Q1 FY2025 Earnings Presentation on 6ix